Hithanadura Janaka de Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hithanadura Janaka de Silva has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Madunil Anuk Niriella
Department of Medicine, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
6 shared publications - Anuradhani Kasturiratne
Affiliation Department of Public Health, Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
3 shared publications Ananda Rajitha Wickramasinghe
University of Kelaniya
2 shared publications- Anuradha Supun Dassanayake
Colombo North Centre for Liver Disease, Faculty of Medicine University of Kelaniya Ragama Sri Lanka
2 shared publications Arjuna Priyadarshin De Silva
Faculty of Medicine, University of Kelaniya, Sri Lanka
2 shared publicationsNorihiro Kato
National Center for Global Health and Medicine, Toyama
2 shared publications
Latest Publications
- Open Access
- 26 September 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (3) , 275-278
Management of Irritable Bowel Syndrome: The Role of Digital Health Technologies
Functional Gastrointestinal Disorders (FGIDs), including conditions such as irritable bowel syndrome (IBS) and functional dyspepsia, affect millions worldwide, significantly impairing quality of life and increasing healthcare utilization. These disorders are multifactorial and complex, with several subtypes, making diagnosis and management challenging. This review explores the emerging role of digital health technologies and artificial intelligence(AI) in transforming FGID diagnosis and treatment. We focus on wearable devices, capsule-based diagnostics, mobile health applications, and AI-powered virtual assistants, highlighting how these innovations address the limitations of traditional investigative and management approaches. Additionally, we assess the impact of these digital advancements on patient outcomes, healthcare efficiency, and real-time symptom monitoring. Finally, we examine the challenges associated with data privacy, accuracy, and reliability in digital health solutions and propose future directions for technological advancements in FGID management.
- 26 September 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (3) , 275-278
Open AccessManagement of Irritable Bowel Syndrome: The Role of Digital Health Technologies
Functional Gastrointestinal Disorders (FGIDs), including conditions such as irritable bowel syndrome (IBS) and functional dyspepsia, affect millions worldwide, significantly impairing quality of life and increasing healthcare utilization. These disorders are multifactorial and complex, with several subtypes, making diagnosis and management challenging. This review explores the emerging role of digital health technologies and artificial intelligence(AI) in transforming FGID diagnosis and treatment. We focus on wearable devices, capsule-based diagnostics, mobile health applications, and AI-powered virtual assistants, highlighting how these innovations address the limitations of traditional investigative and management approaches. Additionally, we assess the impact of these digital advancements on patient outcomes, healthcare efficiency, and real-time symptom monitoring. Finally, we examine the challenges associated with data privacy, accuracy, and reliability in digital health solutions and propose future directions for technological advancements in FGID management.
- Open Access
- 9 May 2024
- Published by MDPI AG in Preprints.org
Gilbert’s Syndrome: The Good, the Bad and the Ugly
Gilbert's syndrome (GS) is a common hereditary condition characterized by mild increases in serum bilirubin levels due to inherited defects in bilirubin metabolism. This review, based on data from peer-reviewed articles and journals spanning from 1977 to January 2024, provides a comprehensive overview of over four decades of research on GS. Early studies primarily focused on defining the clinical and genetic characteristics of the syndrome, laying the foundation for subsequent investigations. More recent research has delved into the genetic mechanisms underlying the reduced expression of bilirubin UDP-glucuronosyltransferase, which has significantly enhanced our understanding of the pathogenesis of GS. Furthermore, recent studies have shed light on the clinical implications of GS, including its association with non-alcoholic fatty liver disease and mortality risk, highlighting the complex interplay between genetic factors, bilirubin metabolism, and clinical outcomes. Despite its generally benign nature, thorough research is essential to fully understand the impact of GS on patients' lives. This review emphasizes the importance of ongoing research to deepen our understanding of GS and its broader implications.
- 9 May 2024
- Published by MDPI AG in Preprints.org
Open AccessGilbert’s Syndrome: The Good, the Bad and the Ugly
Gilbert's syndrome (GS) is a common hereditary condition characterized by mild increases in serum bilirubin levels due to inherited defects in bilirubin metabolism. This review, based on data from peer-reviewed articles and journals spanning from 1977 to January 2024, provides a comprehensive overview of over four decades of research on GS. Early studies primarily focused on defining the clinical and genetic characteristics of the syndrome, laying the foundation for subsequent investigations. More recent research has delved into the genetic mechanisms underlying the reduced expression of bilirubin UDP-glucuronosyltransferase, which has significantly enhanced our understanding of the pathogenesis of GS. Furthermore, recent studies have shed light on the clinical implications of GS, including its association with non-alcoholic fatty liver disease and mortality risk, highlighting the complex interplay between genetic factors, bilirubin metabolism, and clinical outcomes. Despite its generally benign nature, thorough research is essential to fully understand the impact of GS on patients' lives. This review emphasizes the importance of ongoing research to deepen our understanding of GS and its broader implications.
- Open Access
- 22 November 2022
- Published by Sri Lanka Journals Online in Ceylon Journal of Medical Science
- Vol. 59
Supporting affordable healthcare through innovative research
- 22 November 2022
- Published by Sri Lanka Journals Online in Ceylon Journal of Medical Science
- Vol. 59
Open AccessSupporting affordable healthcare through innovative research
- Open Access
- 19 October 2022
- Published by Sri Lanka Journals Online in Ceylon Medical Journal
- Vol. 67 (2) , 45-51
Alcohol use and alcoholic fatty liver disease: a prospective, communitybased study among adults in an urban community in Sri Lanka
- 19 October 2022
- Published by Sri Lanka Journals Online in Ceylon Medical Journal
- Vol. 67 (2) , 45-51
Open AccessAlcohol use and alcoholic fatty liver disease: a prospective, communitybased study among adults in an urban community in Sri Lanka
- Open Access
- 15 June 2022
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 65 (6) , 304-311
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial
Background: Childhood obesity is a global problem associated with metabolic abnormalities. The gut-liver axis is thought to play a major role in its pathogenesis. Probiotics are known to alter the gut microbiota and, therefore, could be a therapeutic option in the management of childhood obesity-related complications.Purpose: This double-blind randomized placebo-controlled trial evaluated the effects of probiotics on metabolic derangement in obese children with nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis (NAFLD/NASH).Methods: Obese children with NAFLD/NASH treated at the nutrition clinic of the University Paediatric Unit at Lady Ridgeway Hospital, Colombo, were recruited. Anthropometry, body fat, metabolic derangement, and liver ultrasound scan (USS) results were evaluated at baseline and after 6 months. Transient elastography (FibroScan) was performed on a subsample of these patients. Eighty-four patients were recruited and randomized into the probiotics (n=43) and placebo (n= 41) groups. The mean age was 11.3±1.9 versus 12.1±1.5 years in the probiotic and placebo groups, respectively. Baseline parameters including liver disease stage on USS, body fat percentage, fasting blood sugar, lipid profile, liver function, and C-reactive protein showed no significant intergroup differences.Results: In the probiotic group, a statistically significant reduction in body mass index was noted from the baseline value. However, the reduction was not significant compared with the placebo group. There was a significant reduction in triglycerides, aspartate transaminase (AST), alanine aminotransferase (ALT), AST/ALT ratio, and alkaline phosphatase in the placebo group over the treatment period. Although the liver disease stage on USS improved from stage II–III to stage I in a small number of patients in the probiotic-treated group, transient elastography performed in a subsample did not demonstrate significant improvement in either group.Conclusion: Our results indicate that probiotics have no advantage over lifestyle modification for improving obesityassociated metabolic derangement in children.
- 15 June 2022
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 65 (6) , 304-311
Open AccessEffects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial
Background: Childhood obesity is a global problem associated with metabolic abnormalities. The gut-liver axis is thought to play a major role in its pathogenesis. Probiotics are known to alter the gut microbiota and, therefore, could be a therapeutic option in the management of childhood obesity-related complications.Purpose: This double-blind randomized placebo-controlled trial evaluated the effects of probiotics on metabolic derangement in obese children with nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis (NAFLD/NASH).Methods: Obese children with NAFLD/NASH treated at the nutrition clinic of the University Paediatric Unit at Lady Ridgeway Hospital, Colombo, were recruited. Anthropometry, body fat, metabolic derangement, and liver ultrasound scan (USS) results were evaluated at baseline and after 6 months. Transient elastography (FibroScan) was performed on a subsample of these patients. Eighty-four patients were recruited and randomized into the probiotics (n=43) and placebo (n= 41) groups. The mean age was 11.3±1.9 versus 12.1±1.5 years in the probiotic and placebo groups, respectively. Baseline parameters including liver disease stage on USS, body fat percentage, fasting blood sugar, lipid profile, liver function, and C-reactive protein showed no significant intergroup differences.Results: In the probiotic group, a statistically significant reduction in body mass index was noted from the baseline value. However, the reduction was not significant compared with the placebo group. There was a significant reduction in triglycerides, aspartate transaminase (AST), alanine aminotransferase (ALT), AST/ALT ratio, and alkaline phosphatase in the placebo group over the treatment period. Although the liver disease stage on USS improved from stage II–III to stage I in a small number of patients in the probiotic-treated group, transient elastography performed in a subsample did not demonstrate significant improvement in either group.Conclusion: Our results indicate that probiotics have no advantage over lifestyle modification for improving obesityassociated metabolic derangement in children.
- Open Access
- 4 May 2022
- Published by Sri Lanka Journals Online in Ceylon Medical Journal
- Vol. 67 (1) , 1-4
Non-alcoholic fatty liver disease: a Sri Lankan perspective
- 4 May 2022
- Published by Sri Lanka Journals Online in Ceylon Medical Journal
- Vol. 67 (1) , 1-4
Open AccessNon-alcoholic fatty liver disease: a Sri Lankan perspective
- Open Access
Spatially regulated designs of incidence surveys can match the precision of classical survey designs whilst requiring smaller sample sizes: the case of snakebite in Sri Lanka
Background Snakebite envenoming is a neglected tropical disease. Data from the worst affected countries are limited because conducting epidemiological surveys is challenging. We assessed the utility of inhibitory geostatistical design with close pairs (ICP) to estimate snakebite incidence. Methods The National Snakebite Survey (NSS) in Sri Lanka adopted a multistage cluster sampling design, based on population distribution, targeting 1% of the country’s population. Using a simulation-based study, we assessed predictive efficiency of ICP against a classical survey design at different fractions of the original sample size of the NSS. We also assessed travel distance, time taken to complete the survey, and sensitivity and specificity for detecting high-risk areas for snake envenoming, when using these methods. Results A classical survey design with 33% of the original NSS sample size was able to yield a similar predictive efficiency. ICP yielded the same at 25% of the NSS sample size, a 25% reduction in sample size compared to a classical survey design. ICP showed >80% sensitivity and specificity for detecting high-risk areas of envenoming when the sampling fraction was >20%. When ICP was adopted with 25% of the original NSS sample size, travel distance was reduced by >40% and time to conduct the survey was reduced by >75%. Conclusions This study showed that snakebite envenoming incidence can be estimated by adopting an ICP design with similar precision at a lower sample size than a classical design. This would substantially save resources and time taken to conduct epidemiological surveys and may be suited for low resource settings. Key messages Inhibitory geostatistical design with close pairs (ICP) for incidence surveys can match the precision of classical survey designs at lower sample sizes. The ICP design showed a lower predictive variance than classical design, indicating ICP designs were able to produce more reliable predictions. The ICP design showed a lower time to complete the survey than the classical sampling method. Although primary sampling units in the ICP design maintain a minimum distance between two units, ICP did not increase travel distance compared to the classical survey design. Resource requirements and time to complete surveys can be reduced without increasing the distance to travel by adopting ICP design for epidemiological surveys.
Open AccessSpatially regulated designs of incidence surveys can match the precision of classical survey designs whilst requiring smaller sample sizes: the case of snakebite in Sri Lanka
Background Snakebite envenoming is a neglected tropical disease. Data from the worst affected countries are limited because conducting epidemiological surveys is challenging. We assessed the utility of inhibitory geostatistical design with close pairs (ICP) to estimate snakebite incidence. Methods The National Snakebite Survey (NSS) in Sri Lanka adopted a multistage cluster sampling design, based on population distribution, targeting 1% of the country’s population. Using a simulation-based study, we assessed predictive efficiency of ICP against a classical survey design at different fractions of the original sample size of the NSS. We also assessed travel distance, time taken to complete the survey, and sensitivity and specificity for detecting high-risk areas for snake envenoming, when using these methods. Results A classical survey design with 33% of the original NSS sample size was able to yield a similar predictive efficiency. ICP yielded the same at 25% of the NSS sample size, a 25% reduction in sample size compared to a classical survey design. ICP showed >80% sensitivity and specificity for detecting high-risk areas of envenoming when the sampling fraction was >20%. When ICP was adopted with 25% of the original NSS sample size, travel distance was reduced by >40% and time to conduct the survey was reduced by >75%. Conclusions This study showed that snakebite envenoming incidence can be estimated by adopting an ICP design with similar precision at a lower sample size than a classical design. This would substantially save resources and time taken to conduct epidemiological surveys and may be suited for low resource settings. Key messages Inhibitory geostatistical design with close pairs (ICP) for incidence surveys can match the precision of classical survey designs at lower sample sizes. The ICP design showed a lower predictive variance than classical design, indicating ICP designs were able to produce more reliable predictions. The ICP design showed a lower time to complete the survey than the classical sampling method. Although primary sampling units in the ICP design maintain a minimum distance between two units, ICP did not increase travel distance compared to the classical survey design. Resource requirements and time to complete surveys can be reduced without increasing the distance to travel by adopting ICP design for epidemiological surveys.
- Open Access
- 15 September 2021
- Published by Sri Lanka Journals Online in Journal of the Postgraduate Institute of Medicine
- Vol. 8 (2) , 157
Substance use disorders and their correlates among inmates in a Sri Lankan prison
- 15 September 2021
- Published by Sri Lanka Journals Online in Journal of the Postgraduate Institute of Medicine
- Vol. 8 (2) , 157
Open AccessSubstance use disorders and their correlates among inmates in a Sri Lankan prison
- Open Access
- 1 July 2021
- Published by Elsevier in Toxicon: X
- Vol. 9-10, 100074
Chronic health effects and cost of snakebite
- 1 July 2021
- Published by Elsevier in Toxicon: X
- Vol. 9-10, 100074
Open AccessChronic health effects and cost of snakebite
- 1 March 2021
- Published by Elsevier in European Journal of Radiology
- Vol. 136, 109516
The clinical utility of accurate NAFLD ultrasound grading: Results from a community-based, prospective cohort study
- 1 March 2021
- Published by Elsevier in European Journal of Radiology
- Vol. 136, 109516
The clinical utility of accurate NAFLD ultrasound grading: Results from a community-based, prospective cohort study